ASX - By Stock
|
ZLD |
Re:
Ann: Appendix 4C Cash Flow Report
|
|
cue
|
6 |
2.9K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
6
|
2.9K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Appendix 4C Cash Flow Report
|
|
cue
|
6 |
2.9K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
6
|
2.9K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Summary
|
|
cue
|
37 |
18K |
0 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
37
|
18K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Summary
|
|
cue
|
37 |
18K |
6 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
37
|
18K
|
6
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Appendix 4C Cash Flow Report
|
|
cue
|
6 |
2.9K |
2 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
6
|
2.9K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Summary
|
|
cue
|
37 |
18K |
5 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
37
|
18K
|
5
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Appendix 4D & FY24 Interim Financial Report
|
|
cue
|
9 |
2.7K |
3 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
9
|
2.7K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Summary
|
|
cue
|
37 |
18K |
1 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
37
|
18K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Summary
|
|
cue
|
37 |
18K |
2 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
37
|
18K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Summary
|
|
cue
|
37 |
18K |
1 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
37
|
18K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Summary
|
|
cue
|
37 |
18K |
3 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
37
|
18K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Summary
|
|
cue
|
37 |
18K |
3 |
07/01/24 |
07/01/24 |
ASX - By Stock
|
37
|
18K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
0 |
24/12/23 |
24/12/23 |
ASX - By Stock
|
28
|
8.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
0 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
28
|
8.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
0 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
28
|
8.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
0 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
28
|
8.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
0 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
28
|
8.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
0 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
28
|
8.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
0 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
28
|
8.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
0 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
28
|
8.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
0 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
28
|
8.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
2 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
28
|
8.9K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
0 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
28
|
8.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
0 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
28
|
8.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
2 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
28
|
8.9K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
0 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
28
|
8.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
2 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
28
|
8.9K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
7 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
28
|
8.9K
|
7
|
|
ASX - By Stock
|
ZLD |
Re:
Levin health
|
|
cue
|
28 |
8.9K |
0 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
28
|
8.9K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: 2023 Annual General Meeting Presentation
|
|
cue
|
12 |
5.4K |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
12
|
5.4K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: 2023 Annual General Meeting Presentation
|
|
cue
|
12 |
5.4K |
2 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
12
|
5.4K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: 2023 Annual General Meeting Presentation
|
|
cue
|
12 |
5.4K |
1 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
12
|
5.4K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: 2023 Annual General Meeting Presentation
|
|
cue
|
12 |
5.4K |
0 |
25/11/23 |
25/11/23 |
ASX - By Stock
|
12
|
5.4K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Proposed issue of securities - ZLD
|
|
cue
|
1 |
566 |
4 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
1
|
566
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Annual Report to shareholders
|
|
cue
|
14 |
5.7K |
4 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
14
|
5.7K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Annual Report to shareholders
|
|
cue
|
14 |
5.7K |
4 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
14
|
5.7K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Annual Report to shareholders
|
|
cue
|
14 |
5.7K |
2 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
14
|
5.7K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Annual Report to shareholders
|
|
cue
|
14 |
5.7K |
8 |
15/10/23 |
15/10/23 |
ASX - By Stock
|
14
|
5.7K
|
8
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Annual Report to shareholders
|
|
cue
|
14 |
5.7K |
17 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
14
|
5.7K
|
17
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
cue
|
217 |
71K |
3 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
217
|
71K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
cue
|
217 |
71K |
7 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
217
|
71K
|
7
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
cue
|
217 |
71K |
13 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
217
|
71K
|
13
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
cue
|
217 |
71K |
4 |
18/06/23 |
18/06/23 |
ASX - By Stock
|
217
|
71K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Amendment to ASX announcement - Zelira's diabetic nerve pai
|
|
cue
|
9 |
4.9K |
1 |
11/06/23 |
11/06/23 |
ASX - By Stock
|
9
|
4.9K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Amendment to ASX announcement - Zelira's diabetic nerve pai
|
|
cue
|
9 |
4.9K |
3 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
9
|
4.9K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Amendment to ASX announcement - Zelira's diabetic nerve pai
|
|
cue
|
9 |
4.9K |
6 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
9
|
4.9K
|
6
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
cue
|
217 |
71K |
3 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
217
|
71K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
cue
|
217 |
71K |
4 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
217
|
71K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
cue
|
217 |
71K |
2 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
217
|
71K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
cue
|
217 |
71K |
6 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
217
|
71K
|
6
|
|